Ribonexus
PrivateLast Round
Grant
Apr 12, 2022
Total Funding Raised
$6.89M
Company Overview
Ribonexus is a biotechnology company that develops therapies to overcome resistance to current targeted treatments in cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ribonexus Comparables
Compare Ribonexus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SJP Biotec GmbH | 82% | |
| PIC Therapeutics | 80% | |
| Ribometrix | 75% | |
Ribonexus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 12, 2022 | ||||
| Seed | Sep 27, 2021 |
Ribonexus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Crédit Mutuel Innovation | Seed |
| Bpifrance | Grant |
| AdBio partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 12, 2022
$2.19M grant round from Bpifrance.
- Sep 27, 2021
$4.7M round led by Advent France Biotechnology
Ribonexus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ribonexus's valuation, stock price, and market status.